How to Read a Liver Ultrasound and Your Results

Demystify your liver ultrasound. Learn to interpret images, recognize normal vs. abnormal findings, and understand your official report.

A liver ultrasound report describes the size, texture, blood flow, and any visible abnormalities in your liver using a standardized set of terms and measurements. Reading it yourself can feel like decoding a foreign language, but once you know what the key phrases mean, most reports follow a predictable structure. The report typically covers the liver’s overall appearance (its “echogenicity”), measurements, the condition of blood vessels running through it, whether any distinct masses or lesions are present, and sometimes a stiffness reading. Each of these sections tells a different part of the story about your liver’s health.

What a Healthy Liver Looks Like on Ultrasound

The first thing a sonographer evaluates is the liver’s overall echo pattern, which refers to how the sound waves bounce back from the tissue. A healthy liver has a smooth, uniform texture that appears as a consistent shade of gray on the screen. It should be roughly the same brightness as, or just slightly brighter than, the nearby kidney cortex. The edges of the liver should be sharp and smooth, the internal blood vessels should be clearly visible, and the diaphragm behind the liver should be easy to see through the tissue.

Ultrasound anatomy of the liver relies on three sets of internal landmarks: the portal veins, the hepatic veins, and the bile ducts. These structures let the sonographer mentally divide the liver into segments, which is how the report pinpoints where something is located. If your report says “segment 6” or “the right posterior lobe,” those labels come from this vascular road map. A study of healthy patients confirmed that the relationship between these anatomic landmarks and their ultrasound appearance is consistent and reliable, making it possible to map liver anatomy on the screen with good precision.

In adults, a normal liver span measured at the midclavicular line is generally in the range of 12 to 16 cm, though this varies with body size. In children, the range is quite different. A large pediatric study found that liver size at birth ranges from about 5 to 5.5 cm, increasing gradually to a maximum around 17 cm in older teenagers, with height being a better predictor of expected liver size than age alone. If your report mentions liver size, what matters is whether the number falls within the expected range for your body. A slightly enlarged liver is common and not always alarming, but significant enlargement or shrinkage can signal underlying disease.

Fatty Liver and What the Grades Mean

Probably the most common abnormal finding on a liver ultrasound is steatosis, the medical term for fatty liver. Your report may describe this as “increased echogenicity” or “hepatic steatosis,” and it is often assigned a grade from 0 to 3. Understanding these grades gives you a much clearer picture of where you stand.

  • Grade 0 (absent): The liver looks normal, with no unusual brightness.
  • Grade 1 (mild): There is a slight, diffuse increase in brightness, but you can still see the diaphragm and the walls of the portal vein clearly.
  • Grade 2 (moderate): The brightness is more pronounced, and the portal vein walls and diaphragm start to look a little blurry or washed out.
  • Grade 3 (severe): The liver is markedly bright, and the portal vein wall, diaphragm, and the back portion of the right lobe of the liver are hard to see or completely obscured.

This grading system is semi-quantitative, meaning it relies partly on the sonographer’s judgment rather than an exact measurement. A grade 1 finding is extremely common in the general population and does not necessarily mean you have liver disease, but it does indicate fat accumulation that may warrant lifestyle adjustments or monitoring. Grade 2 and especially grade 3 findings tend to prompt further evaluation, such as blood work or a more detailed imaging study.

One thing to keep in mind: ultrasound is good at detecting moderate-to-severe fatty liver but can miss very mild cases. It also cannot tell the difference between simple fatty liver and the more concerning inflammatory form of fatty liver disease. That distinction usually requires additional testing.

Signs of Fibrosis and Cirrhosis

If your liver has been damaged over time by chronic hepatitis, heavy alcohol use, or advanced fatty liver disease, the tissue may develop scarring called fibrosis. When fibrosis becomes severe and widespread, it is called cirrhosis. Ultrasound can pick up several clues that suggest this is happening, though it is better at detecting advanced disease than early-stage scarring.

The most telling sign is the surface of the liver. A healthy liver has a smooth surface, while a cirrhotic liver often looks lumpy or nodular. In a study of 300 patients, liver surface nodularity had the highest diagnostic accuracy for detecting severe fibrosis or cirrhosis, with a specificity of 95%. When this sign was present, the probability of severe fibrosis or cirrhosis jumped from about 35% to 86%. Using a high-frequency probe to examine the liver surface, researchers have classified three patterns: a normal smooth surface, a surface with a focal abnormality, and diffuse irregularity. That diffuse irregularity pattern had a sensitivity of about 88% and specificity of about 82% for cirrhosis.

Other signs your report might mention include a coarsened or heterogeneous texture of the liver tissue, an enlarged spleen, the presence of fluid in the abdomen (ascites), or visible collateral blood vessels. None of these signs alone confirms cirrhosis, but when several appear together on the same scan, the picture becomes more convincing. If your report describes the liver as “coarsened” or mentions surface irregularity, your doctor will probably want to assess liver stiffness or order blood work to determine the severity.

Understanding the Doppler Section of Your Report

Most liver ultrasound reports include a section on blood flow, measured using Doppler mode. This part of the exam tracks how blood moves through three key sets of vessels: the portal vein (which carries blood from the intestines to the liver), the hepatic veins (which drain blood out of the liver), and the hepatic artery (which supplies oxygen-rich blood to the liver). The patterns of flow in these vessels reveal a lot about how well the liver is working.

In a healthy liver, blood in the portal vein flows steadily toward the liver, typically at a speed of around 15 to 25 cm per second. The hepatic veins have a distinctive pulsating waveform that reflects pressure changes from the heart. The hepatic artery shows a low-resistance flow pattern. When the liver becomes cirrhotic, all three of these patterns can change. Portal vein flow tends to slow down and can even reverse direction in advanced cases. The pulsating waveform in the hepatic veins flattens out. And the resistance in the hepatic artery goes up.

If your report says something like “hepatopetal portal flow,” that means blood is flowing in the normal direction (toward the liver). “Hepatofugal flow” means it is flowing backward, away from the liver, which is an abnormal finding that points to severe portal hypertension. A “resistive index” (RI) is a number between 0 and 1 that describes how much resistance there is in an artery. In the hepatic artery, a higher-than-normal RI can suggest cirrhosis or other problems with blood flow through the liver.

Focal Lesions and What They Usually Are

One of the most anxiety-inducing things a liver ultrasound report can say is that a “lesion” or “mass” was found. Before you panic, know that the vast majority of incidentally discovered liver lesions are benign. The two most common are hemangiomas and simple cysts.

A hemangioma is a tangle of blood vessels that forms a benign mass. The classic appearance on ultrasound is a small, uniformly bright (hyperechoic) mass, usually under 3 cm, with well-defined edges and a bit of acoustic enhancement behind it, meaning the area behind the mass appears slightly brighter because the sound waves pass through the blood-filled spaces easily. However, not all hemangiomas look textbook. A study of 271 hemangiomas found that only about a third showed the classic uniformly bright pattern. Others appeared darker than the surrounding liver, had a mixed appearance, or were the same shade as the surrounding tissue. In those cases where the hemangioma blended in with the liver, a bright rim around the mass was the giveaway. When appearance on standard ultrasound is ambiguous, contrast-enhanced ultrasound or MRI can usually confirm the diagnosis.

Simple cysts are even easier to recognize: they appear as completely dark (anechoic), round, thin-walled pockets of fluid with bright enhancement behind them. They are almost always harmless and require no follow-up unless they are very large or causing symptoms.

Two other benign lesions that sometimes appear are focal nodular hyperplasia (FNH) and hepatocellular adenoma. Telling them apart matters because adenomas carry a small risk of bleeding or turning malignant, while FNH is virtually always harmless. Doppler ultrasound can help differentiate them: FNH tends to show arterial blood flow radiating outward from a central scar, while adenomas show a different pattern with venous-type blood flow inside the mass and pulsatile or continuous flow around its edges. Using power Doppler imaging, one study correctly distinguished the two in about 90% of cases.

The LI-RADS Scoring System

If you are at elevated risk for liver cancer, perhaps because of cirrhosis or chronic hepatitis B, your ultrasound report may use a scoring system called LI-RADS, which stands for Liver Imaging Reporting and Data System. Developed by the American College of Radiology, this system standardizes how findings are reported so that different doctors interpret the same images the same way.

For surveillance ultrasound, LI-RADS uses two scores. The detection score tells your doctor what was found:

  • US-1 (Negative): No suspicious lesion was seen.
  • US-2 (Subthreshold): A lesion was seen, but it is too small or indistinct to characterize, typically under 10 mm.
  • US-3 (Positive): A lesion was seen that warrants further evaluation with a more detailed imaging study like CT or MRI.

The visualization score tells your doctor how well the ultrasound was able to see the liver:

  • Visualization A: No or minimal limitations. The exam was technically good.
  • Visualization B: Moderate limitations. Some areas were hard to see, possibly due to body habitus or overlying bowel gas.
  • Visualization C: Severe limitations. The exam may not have been adequate for surveillance purposes.

A visualization C score does not mean something is wrong with your liver. It means the ultrasound itself was suboptimal, and your doctor may recommend a different imaging method for future screening. For patients with cirrhosis, guidelines generally recommend surveillance ultrasound every six months. A Taiwanese cohort study found that this six-month interval improved early-stage cancer detection, increased the chance of receiving curative treatment, and was linked to longer survival compared to less frequent screening.

Elastography Numbers on Your Report

Some ultrasound exams include an elastography measurement, which estimates how stiff your liver tissue is. Stiffness is a surrogate marker for fibrosis: the more scar tissue present, the stiffer the liver becomes. This technology has been used clinically for close to two decades and can help stage fibrosis without the need for a needle biopsy.

The result is reported in kilopascals (kPa) or meters per second (m/s), depending on the technique. Generally, values under about 7 kPa suggest little to no fibrosis, while values above 12 to 14 kPa raise concern for advanced fibrosis or cirrhosis. The exact thresholds vary depending on the specific elastography method used and the cause of your liver disease, so the number on your report needs to be interpreted in context.

Shear-wave elastography, one of the newer methods, has shown high diagnostic accuracy, especially for advanced fibrosis and cirrhosis. In a study comparing it to transient elastography (the older technique), shear-wave elastography had a higher success rate at obtaining measurements, completing the exam in nearly 99% of patients compared to about 90% for transient elastography. It also showed higher accuracy across all stages of fibrosis. That said, both techniques correlate well with fibrosis stage, and the choice between them often comes down to what equipment your imaging center has.

Be aware that stiffness readings can be falsely elevated by things that have nothing to do with fibrosis: eating recently, active liver inflammation, congestion from heart failure, or even holding your breath too aggressively during the measurement. If your number seems unexpectedly high, your doctor may want to repeat the test under more controlled conditions.

When Contrast-Enhanced Ultrasound Enters the Picture

Standard ultrasound uses only sound waves, but in some cases your doctor may order a contrast-enhanced ultrasound (CEUS). This involves injecting a small amount of microbubble contrast agent into a vein, which lights up blood vessels inside the liver and any lesions in real time. The technique is particularly useful for characterizing a mass that was found on a regular ultrasound but could not be confidently identified as benign or malignant.

In a phase 3 multicenter trial, contrast-enhanced ultrasound had an accuracy of about 89% for characterizing focal liver lesions, compared to roughly 68% for unenhanced ultrasound and about 81% for dynamic CT. A separate international multicenter study found that CEUS was about 30% more sensitive and 16% more specific than CT and MRI for characterizing focal liver lesions, with even higher numbers in the subset of patients who had biopsy confirmation.

CEUS is not used as a first-line screening tool. It enters the picture when a regular scan turns up something that needs further investigation. Its advantage over CT and MRI is that it is radiation-free, can be done right at the bedside, and provides real-time dynamic imaging rather than static snapshots. For people with kidney problems who cannot receive CT or MRI contrast dyes, CEUS is a valuable alternative because the microbubbles are cleared through the lungs rather than the kidneys. Research has also suggested that contrast-enhanced ultrasound findings may even help predict how aggressive a liver cancer is, potentially reducing the need for biopsy in some situations.

Artifacts and Technical Limitations Worth Knowing About

Ultrasound images are not photographs. They are constructed from reflected sound waves, which means they are susceptible to artifacts, or false images that do not correspond to actual structures. Knowing this exists can save you unnecessary worry if something on your report sounds strange.

Common artifacts include mirror images (where a structure near the diaphragm appears to be duplicated above it), reverberation (repeating echoes that create false lines), and acoustic shadowing (where structures like ribs or gallstones block the sound waves and create dark bands behind them). On standard grayscale ultrasound, these are generally well understood and easily recognized by experienced sonographers.

Contrast-enhanced ultrasound introduces its own set of potential artifacts, including pseudowashout (where the contrast agent appears to leave a lesion too quickly, mimicking malignancy), signal saturation (where too much contrast obscures the image), and pseudoenhancement (where a lesion appears brighter than it really is due to the surrounding contrast). Experienced radiologists know to look for these and can usually distinguish artifact from real pathology, but it is one reason a single unusual finding may lead to a recommendation for a follow-up scan rather than immediate action.

Body habitus matters too. A thick layer of subcutaneous fat between the probe and the liver degrades image quality. This is one reason why your report may include a visualization score or a comment about limited views. It is also why fasting before a liver ultrasound is sometimes recommended. A randomized trial found that fasting improved image quality for male patients in particular, though overall the difference between fasting and non-fasting groups did not reach statistical significance for most liver regions. The gallbladder was the area most affected: about 73% of fasting patients had a completely evaluable gallbladder compared to 56% of non-fasting patients.

Understanding the Language of Your Report

If you have read through your liver ultrasound results and felt lost by the terminology, you are not alone. The field has recognized this problem and is actively working to standardize the language used in liver imaging reports. The American College of Radiology’s LI-RADS program has published a universal liver imaging lexicon that defines 81 terms for describing what is seen on ultrasound, CT, and MRI of the liver. The goal is to make sure that when one radiologist says “echogenic,” another radiologist, and ideally you, can know precisely what that means.

Here are some of the most common terms you will see and what they mean in plain English:

  • Echogenic or hyperechoic: Brighter than normal on the ultrasound image. Often indicates fat or a hemangioma.
  • Hypoechoic: Darker than the surrounding tissue. Could be a cyst, tumor, or area of inflammation.
  • Anechoic: Completely black, meaning it transmits sound perfectly. Almost always fluid, such as in a simple cyst.
  • Heterogeneous: The texture is uneven, with patches of different brightness. Can indicate chronic liver disease or a complex mass.
  • Homogeneous: Uniform texture. Generally a reassuring descriptor.
  • Hepatomegaly: The liver is larger than expected for your body size.
  • Ascites: Free fluid in the abdominal cavity, often a sign of advanced liver disease.

Your report will also likely include the biliary system, meaning the gallbladder and bile ducts. A normal common bile duct in adults measures under about 6 to 7 mm. If the report mentions bile duct dilatation, that suggests something may be blocking the flow of bile, such as a gallstone or a mass at the head of the pancreas. Ultrasound is generally reliable at detecting both fatty liver changes and bile duct dilatation.

Liver Ultrasound in Children

Pediatric liver ultrasound follows the same basic principles as in adults, but the normal ranges are different, and some conditions are unique to children. The liver occupies a proportionally larger part of the abdomen in newborns and infants, and its echo texture can look slightly different depending on the child’s age. A pictorial review of pediatric liver ultrasound emphasizes that familiarity with normal age-related appearances is essential to avoid misinterpreting normal findings as pathology.

Children are more likely to present with certain conditions rarely seen in adults, such as biliary atresia (a blockage of the bile ducts present from birth), hepatoblastoma (a childhood liver tumor), and certain metabolic storage diseases that alter the liver’s appearance. On the other hand, fatty liver disease is becoming increasingly common in children, driven largely by the same dietary and lifestyle factors that cause it in adults. If your child’s report mentions increased echogenicity, the interpretation is similar to an adult report, but the clinical response may differ given the child’s age and context.

Bedside and Point-of-Care Scans Versus Formal Studies

Not all liver ultrasounds are created equal. A formal study performed in a radiology department uses a full-sized machine with specialized probes and is interpreted by a trained radiologist. A point-of-care ultrasound (POCUS) exam, increasingly common in emergency departments and clinics, uses a portable or handheld device and is performed and interpreted by the treating physician at the bedside.

Handheld machines are useful for quick assessments like checking for free fluid, looking at the gallbladder, or confirming that major blood vessels are open. However, a comparison of handheld versus conventional machines in post-liver-transplant patients found that image quality and overall satisfaction scores were lower with the handheld device. While the handheld machine could assess patency of the major veins in almost all patients, it failed to detect signals in smaller hepatic artery branches in a few cases, and the total exam time was longer. The takeaway: a POCUS scan can answer a focused clinical question quickly, but it should not be treated as a replacement for a comprehensive radiology ultrasound when detailed evaluation of the liver is needed.

If you had a bedside scan in the ER and the doctor mentioned a liver finding, that finding will almost always be confirmed or further evaluated with a formal study before any major clinical decisions are made. Think of POCUS as triage imaging: fast and useful but not the last word.